Cerebral Artery Vasoconstriction After Galcanezumab Loading Dose for Migraine Prevention: A Case Report

Cerebral Artery Vasoconstriction After Galcanezumab Loading Dose for Migraine Prevention: A Case Report

Abstract Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies that target CGRP ligands or receptors, may cause a very rare side effect of reversible cerebral vasoconstriction syndrome (RCVS). This study is a case report of a patient who developed cerebral artery vasoconstriction documen...

Full description

Saved in:
Bibliographic Details
Main Authors: Thanin Asawavichienjinda, Nutchawan Jittapiromsak, Andrew Blumenfeld
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-10-01
Series:Pain and Therapy
Subjects:
Case report
Cerebral artery vasoconstriction
CGRP
Galcanezumab
Migraine
Migraine with aura
Online Access:https://doi.org/10.1007/s40122-024-00665-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items